Anita Brikman: Advancing Plasma-Derived Therapies in India Through Global Collaboration
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared a post on LinkedIn:
“India is an emerging partner in strengthening the global ecosystem for plasma-derived therapies and transfusion medicine.
That’s why this week, on behalf of the Plasma Protein Therapeutics Association (PPTA), Joshua Penrod and I are joining Ranjeet Ajmani to meet with regulators, public health experts, blood bank leaders, patient advocates, clinicians, and plasma fractionation professionals across the country.
Our first day included an inspiring meeting with Madhur Gupta and her team at World Health Organization India; they’ve committed to a five-year action plan for implementing blood component therapy and safety standards (including for recovered plasma) across India’s 4,500 plus blood banks.
Our meeting with Central Drugs Standard Control Organization, Drugs Controller General of India, was also helpful in understanding the regulatory path of plasma-derived medicines in India.
Another influential regulatory force is the Indian Pharmacopoeia Commission (IPC); major updates initiated this year align the IPC’s blood product quality and safety monographs to align with international best practice — a critical step forward in the region.
Thank you to M Kalaivani for hosting PPTA.
Collaboration across borders is how we ensure patients everywhere benefit from the life-enabling power of plasma.
Grateful to the many partners across India who are welcoming us and helping move this important work forward.
I look forward to sharing more as our journey continues.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 05:26Paola Mendez Hiraldo: Glenn Ruperto’s Stroke Recovery and the Power of Team-Based Care
-
Jun 25, 2026, 05:19Steven Bell: Lessons in Rapid Stroke Care from Vall d’Hebron University Hospital
-
Jun 25, 2026, 04:48Brianne Martin: Stroke Recovery Is More Than Medical Appointments
-
Jun 24, 2026, 22:30The Clinical Impact of Anaphylaxis-Associated Coagulopathy – JTH
-
Jun 24, 2026, 21:08Martin Haluzík: Semaglutide as a Strategy for Primary Prevention of Cerebrovascular Disease in RA
-
Jun 24, 2026, 19:43New ASH/ISTH 2026 Guidelines for Pediatric Anticoagulant Prophylaxis of VTE Are Now Live – Blood Journals Portfolio
-
Jun 24, 2026, 18:36Maryam Sardar: Timely Anticoagulation in SMV Thrombosis Complicating Acute Pancreatitis
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored